We are live on ! Find out more
CPIX icon

Cumberland Pharmaceuticals
CPIX

23 hedge funds and large institutions have $4.2M invested in Cumberland Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more funds holding

Funds holding: 17 → 23 (+6)

0.55% more ownership

Funds ownership: 16.69% → 17.24% (+0.55%)

29% less capital invested

Capital invested by funds: $5.89M → $4.2M (-$1.69M)

33% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 6

Holders
23
Holders Change
+6
Holders Change %
+35.29%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
6
Closed
–
Calls
$5K
Puts
–
Net Calls
+$5K
Net Calls Change
+$5K

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$67.6K
2
Millennium Management
Millennium Management
New York
+$47.3K
3
Prudential Financial
Prudential Financial
New Jersey
+$10.7K
4
UBS Group
UBS Group
Switzerland
+$8.64K
5
BlackRock
BlackRock
New York
+$626

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$34.6K
2
Two Sigma Investments
Two Sigma Investments
New York
-$15.7K
3
Morgan Stanley
Morgan Stanley
New York
-$3.76K
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$464
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$313
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$1.31M -$34.6K -14,900 -2%
Vanguard Group
2
Vanguard Group
Pennsylvania
$843K +$313 +135 +0%
BCM
3
Bridgeway Capital Management
Texas
$645K – – –
Acadian Asset Management
4
Acadian Asset Management
Massachusetts
$422K – – –
BlackRock
5
BlackRock
New York
$316K +$626 +270 +0.2%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$167K -$313 -135 -0.2%
State Street
7
State Street
Massachusetts
$96.9K – – –
Two Sigma Investments
8
Two Sigma Investments
New York
$86.5K -$15.7K -6,785 -15%
Citadel Advisors
9
Citadel Advisors
Florida
$65.5K +$67.6K +29,122 New
Two Sigma Advisers
10
Two Sigma Advisers
New York
$55.1K -$464 -200 -0.8%
Millennium Management
11
Millennium Management
New York
$46K +$47.3K +20,376 New
Northern Trust
12
Northern Trust
Illinois
$41.3K – – –
Prudential Financial
13
Prudential Financial
New Jersey
$33.5K +$10.7K +4,600 +45%
TCM
14
True Capital Management
California
$27.1K +$27.9K +12,025 New
Morgan Stanley
15
Morgan Stanley
New York
$25.4K -$3.76K -1,619 -13%
UBS Group
16
UBS Group
Switzerland
$8.38K +$8.64K +3,723 New
TRCT
17
Tower Research Capital (TRC)
New York
$8K -$148 -64 -2%
OC
18
Oakworth Capital
Alabama
$6.87K – – –
Dimensional Fund Advisors
19
Dimensional Fund Advisors
Texas
$1.4K +$9 +4 +0%
Wells Fargo
20
Wells Fargo
California
$126 – – –
Bank of America
21
Bank of America
North Carolina
$20 +$21 +9 New
HNB
22
Huntington National Bank
Ohio
$2 – – –
Simplex Trading
23
Simplex Trading
Illinois
– +$225 +97 New

CPIX Hedge Fund Activity: Q4 2022 in Review

23 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q4 2022, worth a combined $4.2M — down 29% from $5.89M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new CPIX positions and 0 closed out — a net gain of 6 holders — while 4 added to existing stakes and 6 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $67.6K. The largest seller was Renaissance Technologies, cutting an estimated $34.6K.

  • 23 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q4 2022, up from 17 in Q3 2022.
  • Funds reported $4.2M of Cumberland Pharmaceuticals stock for Q4 2022, down 29% quarter-over-quarter.
  • 6 funds opened new Cumberland Pharmaceuticals positions in Q4 2022 and 0 closed out, a net change of +6 holders.
  • The largest Cumberland Pharmaceuticals buyer in Q4 2022 was Citadel Advisors, an estimated $67.6K added.
  • The largest Cumberland Pharmaceuticals seller in Q4 2022 was Renaissance Technologies, an estimated $34.6K sold.

Based on aggregated 13F filings for Q4 2022.